A New Sensitive Chromogenic Substrate Assay of Tissue Factor Pathway Inhibitor Type 1
- 1 March 2000
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 97 (6) , 463-472
- https://doi.org/10.1016/s0049-3848(99)00183-8
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Effect of Cholesterol Lowering on Intravascular Pools of TFPI and Its Anticoagulant Potential in Type II HyperlipoproteinemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Measurement of functional and immunologic levels of tissue factor pathway inhibitor. Some methodologic considerationsBlood Coagulation & Fibrinolysis, 1995
- Functional and immunologic methods for the measurement of human tissue factor pathway inhibitorBlood Coagulation & Fibrinolysis, 1995
- Measurement of tissue factor pathway inhibitor in normal and post-heparin plasmaBlood Coagulation & Fibrinolysis, 1994
- Tissue-factor pathway inhibitor and lipoproteins. Evidence for association with and regulation by LDL in human plasma.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Tissue factor pathway inhibitor with high anticoagulant activity is increased in post-heparin plasma and in plasma from cancer patientsBlood Coagulation & Fibrinolysis, 1991
- Chromogenic substrate assay of extrinsic pathway inhibitor (EPI)Blood Coagulation & Fibrinolysis, 1991
- Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitorNature, 1989
- Heparin induces release of extrinsic: Coagulation pathway inhibitor (EPI)Thrombosis Research, 1988
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986